22/01/10
AGENDA FOR ANNUAL REVIEW MEETING 2010
UNIVERSITY OF NAIROBI STD/AIDS COLLABORATIVE GROUP
MAYFAIR COURT HOLIDAY INN, NAIROBI
Monday, January 25, 2010
8:00 – 9:00
Registration
9:00 – 9:30
OPENING CEREMONIES
Chair: Omu Anzala
Opening remarks – Prof. I. Kibwage – Principal, College of Health Sciences, Univ. Nairobi
Reflections on the 30th Anniversary of the Univ. Manitoba / Univ. Collaboration – Prof. F.
Plummer – Public Health Agency of Canada / Univ. Manitoba
Greetings from the University of Manitoba – Prof. D. Barnard – President, Univ. Manitoba
Official opening – Prof. G. Magoha – Vice-Chancellor, Univ. Nairobi
9:30 – 9:40
Break
Session I: Special Presentations
Co-Chairs: Omu Anzala
Joanne Embree
9:40 – 10:00
Unraveling the mysteries of HIV resistance -- progress to date (Frank Plummer – Public
Health Agency of Canada / Univ. Manitoba)
10:00 – 10:20 The Thailand HIV Vaccine trial – what have we learned? Estimating the
potential impact of an AIDS vaccine (Omu Anzala – KAVI / Univ. Nairobi)
10:20 – 10:40 The debate about the importance of concurrency as a driver of the epidemic (Martina
Morris – Univ. Washington)
10:40- 11:00
Coffee / tea
Session II: Epidemiology, Transmission, Risk Factors I
Co-Chairs: Nelly Mugo
Stephen Moses
11:00 – 11:15 Risk factors and potential intervention targets in HIV-1 discordant couples (Brandon
Guthrie – Univ. Washington / Univ. Nairobi)
11:15 – 11:30 Status disclosure amongst HIV-infected adults at Kilifi District Hospital 2009 (Davies
Kimanga – NASCOP / Jomo Kenyatta Univ. / Wellcome Trust / KEMRI)
11:30 – 11:45 Widow inheritance and HIV infection/transmission: where does the inheritor fit in the
risk puzzle? (Kawango Agot, Jacob Odhiambo – Impact-RDO / Univ. Washington /
Univ. Nairobi)
11:45- 12:00
Correlates of HIV infection among young adults in Kisumu 2007-2008 (Anne Gumbe –
CDC / KEMRI)
12:00 – 12:15 Determining the best strategies to use to find persons at high risk of HIV infection for
HIV prevention studies in Kisumu (Anne Adega – CDC / KEMRI)
12:15 – 12:30 A cross-sectional behavioural survey of male sex workers who have sex with men and
women in Nairobi (Anna Seifried, Mary Gichuhi - Univ. Manitoba / Univ. Nairobi)
12:30 – 12:45 To be or not to be a sex worker: perception of female sex workers and non-sex workers
regarding HIV prevention and contraceptive practices (Elizabeth Ngugi – Univ.
Washington / Univ. Nairobi)
12:45- 1:00
The impact of family support on HIV prevention knowledge and practices by infected
youth: The Tuungane Youth Project (Kawango Agot – Impact-RDO / CDC)
1:00 – 2:00
Lunch
Session III: Interventions I – Male circumcision
Co-Chairs: Jeckoniah Ndinya-Achola
Robert Bailey
2:00 – 2:15
Male circumcision for HIV prevention in Nyanza: one year and counting (Kawango
Agot, Walter Obiero - Impact-RDO / Nyanza Reproductive Health Soc. / CDC)
2:15 – 2:30
Male circumcision for HIV prevention in Nyanza: results and lessons from the rapid
results initiative (RRI) (Walter Obiero, June Odoyo, Kawango Agot - Nyanza
Reproductive Health Soc / Impact-RDO / CDC/ FHI)
2:30 – 2:40
Examining the capacity of the private sector health providers to support male
circumcision scale-up in Kenya (Mwende Mbondo – Male Circumcision Consortium /
FHI)
2:40 – 2:50
Assessing the effectiveness of male circumcision outreach services in Kenya (George
Odingo – Male Circumcision Consortium / EngenderHealth)
2:50 – 3:00
Results of a baseline random household survey on male circumcision and HIV in
Kisumu Municipality (Cosam Angwana – Univ. Illinois Chicago / Male Circumcision
Consortium / Univ. Nairobi)
3:00 – 3:10
Voluntary Medical Male Circumcision: An Assessment of Adverse Events (Amy
Herman-Roloff - Univ. Illinois Chicago / Male Circumcision Consortium / Univ.
Nairobi)
3:10 – 3:20
Factors associated with the circumcision decision: baseline results from the risk
compensation study in Nyanza Province (Nelli Westercamp – Univ. Illinois Chicago /
Male Circumcision Consortium / Univ. Nairobi)
3:20 – 3:30
Pilot study of the Shang Ring: a novel male circumcision device for HIV prevention
(Frederick Ndede – EngenderHealth / NASCOP / Cornell Univ.)
3:30 – 3:40
Discussion
3:40 – 4:00
Coffee / tea
4:00 – 5:30
SATELLITE SESSION – ROLLING OUT AND SCALING-UP OF MALE
CIRCUMCISION SERVICES IN KENYA – ISSUES ARISING AND LESSONS
BEING LEARNED (Conveners – Kawango Agot, June Odoyo)
6:00 – 9:00
RECEPTION – Holiday Inn Mayfair Court – co-hosted by Prof. G. Magoha, ViceChancellor, Univ. Nairobi and Dr. D. Barnard, President, Univ. Manitoba; all
conference participants invited to attend
Tuesday, January 26, 2010
Session IV: Interventions II
Co-Chairs: Kishor Mandaliya
Craig Cohen
8:30 – 8:50
Update on the Pre-Exposure Prophylaxis (PrEP) Clinical Trial: Parallel comparison of
Tenofovir and Embricitabine/Tenofovir pre-exposure prophylaxis to prevent HIV-1
acquisition within HIV-1 discordant couples study Kenya and Uganda (Connie Celum –
Univ. Washington / Univ. Nairobi)
8:50 – 9:05
Pre-exposure prophylaxis (PrEP) research: a quantitative ethics appraisal (Madzouka
Kokolo – Univ. Ottawa)
9:05 – 9:25
Phase III multi-center double-blind randomised placebo-controlled effectiveness and
safety study to assess the role of Truvada® in preventing HIV acquisition in women
(Fred Owino, Kawango Agot – Impact-RDO /FHI)
9:25 – 9:40
Secondary HIV prevention: translation and transfer of evidence-based interventions
(Ben Jarabi – Univ. Washington / New York Univ. / Univ. Nairobi)
9:40 – 9:55
HIV-infected males – a neglected lot? (John Mungai – Univ. Manitoba / Univ. Nairobi)
9:55 – 10:15
Evaluating the impact of a large-scale HIV prevention program in Karnataka, South
India (Stephen Moses – Univ. Manitoba)
10:15 – 10:30 Rapid, large-scale mass HIV counselling and testing, malaria and diarrhoea prevention
program in rural Kenya: report on the initial campaign (Alexandre Doyen – Vestergaard
Frandsen / Kenya MOH / CHF)
10:30 – 11:00 Coffee / tea
Session V: Bacterial and Viral STIs
Co-Chairs: Carey Farquhar
King Holmes
11:00 – 11:15 Prevalence, sensitivity of syndromic diagnosis and risk factors for sexually transmitted
infections within a Kenyan HIV incidence cohort study (Fred Otieno – CDC / KEMRI)
11:15 – 11:30 High prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections
among HIV-1 negative MSMs in Coastal Kenya (Eduard Sanders - Wellcome Trust /
KEMRI)
11:30 - 11:45
Quinolone resistance to Neisseria gonorrhoeae in a cohort of young men in Kisumu
2002-2009 (Supriya Mehta – Univ. Illinois Chicago / Univ. Manitoba / Univ. Nairobi)
11:45 – 12:00 Factors associated with prevalent and incident HSV-2 in high-risk Kenyan men (Haile
Okuku – Wellcome Trust / KEMRI)
12:00 – 12:15 HSV-2 incidence, GUD and HIV among circumcised and uncircumcised men in Kisumu
(Robert Bailey – Univ. Illinois Chicago / Univ. Nairobi)
12:15 – 12:30 Relative HIV resistance in Kenyan sex workers is not due to an altered prevalence or
mucosal immune impact of HSV-2 infection (H. Baltzer – Univ. Toronto / Univ.
Manitoba / Univ. Nairobi)
12:30 – 12:45 Prevalence and correlates of cervical precancerous lesions among women in HIV-1
discordant couple relationships in Nairobi (Anne Rositch – Univ. Washington / Univ
North Carolina / Univ. Nairobi)
12:45 – 1:00
Risk factors associated with colposcopy-detected penile lesions in Kenyan men
(Danielle Backes – Univ. North Carolina / Univ. Illinois Chicago / Univ. Manitoba /
Univ. Nairobi)
1:00 – 2:00
Lunch
Session VI: Symposium on Zoonotic Diseases
Co-Chairs: Benson Estambale
Michael Drebot
2:00 – 2:15
Zoonotic diseases, the Kenyan experience (Rosemary Sang-KEMRI)
2:15 – 2:30
From outbreak responses to the development of preventative measures: Ebola and H1N1
experiences (Garry Kobinger- National Microbiology Laboratory, Public Health Agency
of Canada / Univ. Manitoba)
2:30 – 2:45
Understanding Periodic Outbreaks of Rift Valley Fever Outbreaks in East Africa
(Kariuki Njenga - CDC)
2:45 – 3:00
Diagnostic considerations for the identification and characterization of emerging or
under recognized zoonotic pathogens (Michael Drebot – National Microbiology
Laboratory, Public Health Agency of Canada / Univ. Manitoba)
3:00 – 3:15
Changes in livestock systems and their impact on zoonoses and how these are linked to a
one health approach (John McDermott – International Livestock Research Institute
ILRI).
3:15 – 3:30
Risk factors, disease transmission dynamics and predictive potential for early warning
on zoonoses in East Africa. (Philip Nyaga – Univ. Nairobi)
3:30 – 3:45
Investigation of a mysterious disease outbreak in Western Kenya (Omu Anzala – Univ.
Nairobi)
3:45 – 4:00
Coffee / tea
4:00 – 5:30
SATELLITE SESSION - CAPACITY BUILDING FOR THE UNIV. NAIROBI
LEVEL 3 ENHANCED LABORATORY - training, service delivery, sustainability
(Convener – Julius Oyugi)
Wednesday, January 27, 2010
Session VII: Resistance and Susceptibility to HIV Infection and
Disease
Co-chairs: Keith Fowke
Kristina Broliden
8:30 – 8:45
The role of mucosal immunology and protection against HIV transmission at the female
genital tract (Blake Ball – Univ. Manitoba / Univ. Nairobi)
8:45 – 9:00
Setting up multiple barricades along the HIV infection pathway – learning from the
genetic pathway profile of HIV-resistant sex workers (Ma Luo – Univ. Manitoba / Univ.
Nairobi)
9:00 – 9:10
The difference in polyfunctional HIV-specific CD4 responses in HIV-1 exposed
seronegative commercial (ESN) versus newly negative commercial sex workers (Marion
W. Kiguoya– Univ. Manitoba / Univ. Nairobi)
9:10 – 9:20
Identifying specific HIV epitopes responsible for polyfunctional HIV-1 immune
responses that could accord protective immunity in exposed seronegative commercial
sex workers (James Mwanjewe – Univ. Manitoba / Univ. Nairobi)
9:20 – 9:35
HIV viral set point and T cell responses in individuals with naturally-induced virusspecific CD8+ T cell responses prior to HIV acquisition (Rupert Kaul – Univ. Toronto /
Univ. Manitoba / Univ. Nairobi)
9:35 – 9:45
Characterisation of IL-17-secreting cervical CD4+ T cells in female sex workers (Lyle
McKinnon – Univ. Toronto / Univ. Manitoba / Univ. Nairobi)
9:45 – 9:55
Abundant expression of HIV target cells and C-type lectin receptors in the foreskin
tissue of young Kenyan men (Taha Hirbod – Karolinska Inst / Univ. Illinois Chicago /
Univ. Manitoba / Univ. Nairobi)
9:55 – 10:05
Cervical vaginal environment and the epigenetic controls (Ruey-Chyi Su – Univ.
Manitoba / Univ. Nairobi)
10:05 – 10:20 Increased levels of immune activation in the genital tract of healthy young women from
sub-Saharan Africa (Craig Cohen – UCSF / KEMRI)
10:20 – 10:35 Does abstinence make the immune response grow fonder? Exploring the immunological
effects of a break from regular sex work (Keith Fowke – Univ. Manitoba / Univ.
Nairobi)
10:35 – 11:00 Coffee / tea
Session VIII:
Treatment and Care I
Co-Chairs: Dorothy Mbori-Ngacha
Elizabeth Bukusi
11:00 – 11:20 PEPFAR in 2009 – annual report (Lynn Adrian – CDC / KEMRI)
11:20 – 11:35 Longitudinal screening for peripheral neuropathy among patients initiating antiretroviral
therapy in Mombasa (Aabid Ahmed - Bomu Medical Center / New York Univ.)
11:35 – 12:20 The HIV Neurology in Kenya (THINK) study:
Utility of a diagnostic tool for HIV-associated cognitive impairment in Western
Kenya: pilot testing (Judith Kwasa – UCSF / KEMRI)
-
Pattern of neuropsychological performance among HIV-positive patients in
Kenya (Edwin Omondi – UCSF / KEMRI)
-
Utility of HIV-associated neuropathy screening tools in Western Kenya: pilot
testing (Deanna Cettomai – UCSF / KEMRI)
-
Utility of quantitative sensory testing in characterising HIV-associated
peripheral neuropathy in Western Kenya: pilot testing (Deanna Cettomai - UCSF /
KEMRI)
-
Measuring antiretroviral adherence in HIV-infected individuals with and
without cognitive impairment in Western Kenya: pilot testing (Judith Kwasa - UCSF
/ KEMRI)
12:20 – 12:35 Effect of antiretroviral therapy on liver and kidney parameters among HIV-infected
women and their infants in Kisumu (Nicholas Polle – CDC / KEMRI)
12:35 - 12:50
Effects of post-election violence on Kenya’s HIV response and the potential emergence
of HIV drug resistance (Irene Mukui – NASCOP)
12:50 – 1:00
Effect of gender of voice in responding to sensitive sexual behaviour questions using
Audio Computer-Assisted Self-Interview (ACASI) in an HIV incidence cohort study in
Kisumu (Isaiah Oloo – CDC / KEMRI)
1:00 – 2:00
Lunch
Session IX: Interventions III
Co-Chairs: James Kiarie
Barbara Lohman-Payne
2:00 – 2:15
Free-listing and service mapping reveals gender differences in
reproductive and sexual health service perceptions and access (Mercy
Owuor – Univ. Washington / Univ. Nairobi)
2:15 – 2:30
Widow inheritance and sexual networks in Siaya District: developing culturallyappropriate interventions in the context of evolving traditions: baseline results
(Kawango Agot, Rena Otieno - Impact-RDO / Univ. Illinois Chicago / Univ. Nairobi)
2:30 – 2:45
“She’s my sister-law, my visitor, my friend:” Experiences of home follow-up in HIV
research and intervention in Western Kenya (Philister Madiega – CDC / KEMRI)
2:45 – 3:00
Spatial sampling using GPS for a community-enrolled prospective cohort study (Francis
Njiri - Univ. Washington / Univ. Nairobi)
3:00 – 3:15
Barriers in the delivery of HIV and AIDS services to people with disabilities (Sarah
Nduta – Liverpool VCT)
3:15 – 3:45
The HAART Cell Phone Adherence Study:
Preliminary RCT results (Richard Lester – Univ. Manitoba / Univ. British
Columbia / Univ. Nairobi)
-
Use of mobile phones for health care – a qualitative analysis (Sarah Karanja –
Univ. Manitoba / Univ. Nairobi)
Baseline measures of health-related quality of life (Paul Ritvo – York University
/ Univ. Manitoba / Univ. Nairobi)
3:45 – 4:00
Coffee / tea
4:00 – 5:30
SATELLITE MEETING – CELL PHONE STUDY END-OF-PROJECT REPORT
– RESULTS, SCALE-UP ISSUES, FUTURE DIRECTIONS (Convener – Anna
Seifried)
Thursday, January 28, 2010
Session X: Perinatal transmission and HIV/AIDS in children
Co-chairs: Ruth Nduati
Lisa Avery
8:30 – 8:45
Update on the Kesho Bora Clinical Trial: Triple antiretroviral (ARV) prophylaxis during
pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent mother-tochild transmission of HIV-1 (M. Mwaura – ICRH / Univ. Ghent / Univ. Nairobi)
8:45 – 9:00
Infant and young child feeding in the context of HIV (Mildred Mudany – CDC /
KEMRI)
9:00 – 9:15
Evaluation of response to treatment among women exposed to anti-retrovirals for
prevention of mother-to-child HIV transmission: a follow-up of the Kisumu
Breastfeeding Study (KiBS) (Frank Angira – CDC / KEMRI)
9:15 – 9:30
Antiretroviral treatment outcomes among HIV-infected infants exposed to maternal
antiretroviral therapy for prevention of mother-to-child HIV transmission (Lilian Nafisa
– CDC / KEMRI)
9:30 – 9:40
Audit of outcomes of HIV-infected children admitted to the paediatric wards at Kilifi
District Hospital with early commencement of anti-retroviral therapy (Helen Nabwera –
Wellcome Trust / KEMRI)
9:40 – 9:50
Characteristics of paediatric patients lost to follow-up in an HIV care and treatment
clinic in Kisumu (C. Kidiga – FACES / KEMRI / UCSF)
9:50 – 10:00
Successful outcomes following decentralisation of tertiary paediatric HIV care to a
community-based paediatric antiretroviral treatment network, Chiang Rai, Thailand
(Abraham Katana – Oxford Univ. / CDC)
10:00 – 10:10 Long- term treatment outcomes and predictors of mortality in HIV-infected children in
Northern Thailand 2002-2008 (Abraham Katana – Oxford Univ. / CDC)
10:10 – 10:20
Health system factors are more important than stigma in PMTCT interventions uptake
(John Kinuthia – Univ. Washington / Univ. Nairobi)
10:20 – 10:30 Prevention of mother-to-child transmission of HIV-1: from unmet need to unused
service – a new study in Nyanza (John Okanda – CDC / KEMRI / Univ. Washington)
10:35– 11:00
coffee / tea
11:00 – 11:15 HSV-2 suppression to reduce maternal HIV-1 RNA levels during pregnancy and
breastfeeding: a randomised clinical trial (Alison Drake – Univ. Washington / Univ.
Nairobi)
11:15 – 11:30
Is population-based HIV prevalence data able to accurately estimate the number of
women needing PMTCT services? (Ruth Nduati – Univ. Nairobi)
Session XI: Molecular epidemiology
Co-Chairs: Walter Jaoko
Blake Ball
11:30 – 11:45 Multidrug resistant HIV-1 and recombination between variants from the genital tract and
plasma: a longitudinal analysis (Barbara Weiser - Wadsworth Center NY State Dept of
Health, Albany Medical College)
11:45 – 12:00 Evolution and recombination of genes encoding HIV-1 drug resistance and tropism
during antiretroviral therapy (Harold Burger – Wadsworth Center NY State Dept of
Health, Albany Medical College)
12:00 – 12:15 Prospective associations of HIV-specific CD8+ T cell proliferation and IFN-γ ELISPOT
responses with clinical outcome in HIV+ Kenyans (Lyle McKinnon – Univ. Toronto /
Univ. Manitoba / Univ. Nairobi)
12:15 – 12:25 PASER monitoring studies in Kenya to establish HIV drug resistance among adults
using Highly Active Anti-Retroviral Therapy (HAART) (Millicent Olulo – ICRH / Univ.
Ghent / Univ. Nairobi)
12:25 – 12:35 Low-level HIV-1 drug resistance is prevalent in women and children taking
antiretrovirals for prophylaxis and treatment in Kenya (Dara Lehman – Univ.
Washington / Univ. Nairobi)
12:35 – 12:45 Virologic outcomes and drug resistance mutations among HIV-1 positive pregnant
women who received zidovudine, lamivudine and nevirapine for PMTCT (Alex
Kasembeli (CDC / KEMRI)
12:45 – 1:00
Long peptides induce polyfunctional macaque T cells against conserved regions of HIV1 with superior breadth to single-gene vaccines (Tomas Hanke – Oxford Univ)
1:00 – 2:00
lunch
Session XII: Treatment and Care II
Co-Chairs: Christina Mwachari
Rupert Kaul
2:00 – 2:15
Preliminary findings from Kenya’s pilot study on early warning indicators for HIV drug
resistance (Sarah Masyuko – NASCOP / CDC / KEMRI)
2:15 – 2:25
Evaluation of nucleic acid testing on dried blood spots for HIV screening of blood bank
units in Kenya (Julie Okonji – CDC / KEMRI)
2:25 – 2:35
Evaluation of HIV-1 viral load measurement from dried blood spots versus plasma
samples in Kenya (Kenneth Ndiege – CDC / KEMRI)
2:35 – 2:50
Evaluation of a real-time in-house methodology for Mycobacterium tuberculosis
detection from patient samples (Meenu Sharma – Canadian National Reference Centre
for Mycobacteriology / Univ. Manitoba)
2:50 - 3:00
QASI – an international quality assurance program for CD4 enumeration (Blake Ball –
Univ. Manitoba / Univ. Nairobi)
3:00 – 3:10
WHO stage 4 conditions in an HIV-positive cohort in Western Kenya (Patrick Oyaro –
FACES / KEMRI / UCSF)
3:10 – 3:20
Case fatality due to cryptococcal meningitis in a retrospective cohort in Kenya (C.
Kendi - FACES / KEMRI / UCSF)
3:20 – 3:30
Factors associated with quality of life (QoL) in HIV treatment and care clinics in
Western Kenya (Arbogast Oyanga – FACES / UCSF / KEMRI)
3:30 – 3:40
Integration of HIV care with primary health care services: impact on patient knowledge,
satisfaction and stigma in Suba District (Patrick Mbullo – FACES / KEMRI / UCSF)
3:40 – 4:00
Coffee / tea
4:00 – 5:30
SATELLITE MEETING –ICT TECHNOLOGIES FOR HIV SCREENING, CARE
AND PREVENTION (Conveners – Ann Kurth, Tony Kariri)
4:00 – 5:30
SATELLITE MEETING – ICRH BRIEFING – ACTIVITIES AND
PROGRAMMES – PAST, PRESENT AND FUTURE (Convener – Fiona Mbai)
Friday, January 29, 2010
Session XIII: Interventions IV
Co-Chairs: Elizabeth Ngugi
Lisa Mills
8:30 – 8:45
Baseline survey of hospitals preparedness to provide medical and psychosocial care for
gender-based violence survivors in sampled sites in Kenya (Jane Wakahe – GTZ / Univ.
Nairobi)
8:45 – 9:00
Gender-Based Violence and Recovery Centre, Coast Provincial General Hospital –
providing comprehensive care (Christine Katingima – UCSF / ICRH / Univ. Ghent /
Univ. Nairobi)
9:00 – 9:15
Interactive group counseling can change harmful intravaginal practices among female
sex workers (F. Kashonga – Univ. Washington / Univ. Nairobi)
9:15 – 9:30
Scaling up “Families Matter!”: supporting organisations in Kenya to deliver and sustain
a parent-based intervention to prevent HIV in pre-teens (Juliet Ochura – Inst of
TropMed / KEMRI
9:30 – 9:45
Disclosing HIV test results: experiences of HIV-discordant couples in Thika and Nairobi
Districts (Kenneth Ngure – Univ. Washington / Univ. Nairobi)
9:45 – 10:00
Introduction to the CPGH-ICRH Clinical Laboratory (Sammy Wambua - – ICRH / Univ.
Ghent / Univ. Nairobi)
10:00 – 10:15 Community-researcher partnership creation to improve clinical research outcomes
(Jacqueline Naulikha – Univ. Washington / Univ. Nairobi).
10:15 – 10:30 Overcoming structural challenges to ensure high retention in clinical trials: experiences
among HIV-discordant couples enrolled in an HIV prevention study in Kenya
(Josephine Odoyo – UCSF / KEMRI)
10:30 – 11:00 coffee / tea
Session XIV: Family Planning and Reproductive Health
Co-Chairs: Joshua Kimani
Marleen Temmerman
11:00 – 11:15 Service delivery characteristics associated with contraceptive use among youth clients in
voluntary counselling and testing clinics with integrated family planning services (Rose
Otieno-Masaba – FHI)
11:15 – 11:30 Integrating RH/FP with HIV services – the USAID APHIA2 Rift Valley and Coast
Experience (Solomon Marsden – FHI)
11:30 – 11:45 Adaptation of a sexual and reproductive health intervention for adolescents living with
HIV (ALWH): from Healthy Choices for a better and brighter future (Gillian Njika –
Inst. TropMed / KEMRI)
11:45 – 12:00 Sexual and reproductive health needs of adolescents living with HIV in Western Kenya;
findings from focus group discussions with ALWH (Brenda Amimo – Inst. TropMed /
KEMRI)
12:00 – 12:15 Sexual and reproductive health needs of adolescents living with HIV in Western Kenya;
perspectives of caregivers and health service providers (Daniel Adipo – Inst. TropMed /
KEMRI)
12:15 – 12:30 Attitudes towards family planning among HIV-positive pregnant mothers enrolled in a
prevention of mother-to-child transmission (PMTCT) study and among their partners in
Kisumu (Kevin Achola – CDC / KEMRI)
12:30 -12:45
Selecting a suitable population for a vaginal microbicide safety and acceptability trial in
Kisumu: a comparison of two communities (Serah Gitome – Univ. Washington / UCSF /
KEMRI)
12:45 – 1:00
Designing the next generation microbicide leads: Lessons Learned from Phase III trials
(Isaac Malonza – Jhpiego)
1:00 – 2:00
Lunch
Session XV: Epidemiology, Transmission, Risk Factors II
Co-Chairs: Fiona Mbai
Scott McClelland
2:00 – 2:15
Poverty and a lack of empowerment are a hindrance to Prevention with Positive (PwP)
strategies among HIV positive women (Maureen Akolo – Univ. Manitoba / Univ.
Nairobi)
2:15 – 2:30
Health-care seeking prior to HIV seroconversion in Coastal Kenya (Mary Mwangome –
Wellcome Trust / KEMRI)
2:30 – 2:45
Vaginal flora and the risk of HIV-1 acquisition in women: concept and study design for
a recently-funded research proposal (Vernon Mochache – Univ. Washington / Univ.
Nairobi)
2:45 – 3:00
Treatment with antiretroviral therapy is not associated with increased sexual risk
behaviour in Kenyan female sex workers (George Wanje - Univ. Washington / Univ.
Nairobi)
3:00 – 3:15
Effect of cervical infections and their treatment on cervical HIV-1 shedding in women
taking antiretroviral therapy: a prospective study (Ruth Gitau - Univ. Washington /
Univ. Nairobi)
3:15 – 3:30
From local to universal – expanding the concept and practice of health and human rights
among Muslim women in Mombasa (Marleen Renders – Human Rights Centre, Ghent
University Law School / ICRH / Univ. Nairobi)
3:30 – 4:00
SUMMING UP and CLOSING CEREMONIES
Summing up – Benson Estambale, Omu Anzala, Marleen Temmerman
Greetings from the University of Ghent - Prof Paul Van Cauwenberge, Rector,
Univ. Ghent
Closing remarks – Prof. Z. Ngumi, Dean, School of Medicine, Univ. Nairobi (to
be confirmed)
-